Cargando…

Chronic cluster headache and the pituitary gland

BACKGROUND: Cluster headache is classified as a primary headache by definition not caused by an underlying pathology. However, symptomatic cases of otherwise typical cluster headache have been reported. CASE PRESENTATION: A 47-year-old male suffered from primary chronic cluster headache (CCH, ICHD-3...

Descripción completa

Detalles Bibliográficos
Autores principales: De Pue, Annelien, Lutin, Bart, Paemeleire, Koen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788665/
https://www.ncbi.nlm.nih.gov/pubmed/26969187
http://dx.doi.org/10.1186/s10194-016-0614-0
_version_ 1782420747849826304
author De Pue, Annelien
Lutin, Bart
Paemeleire, Koen
author_facet De Pue, Annelien
Lutin, Bart
Paemeleire, Koen
author_sort De Pue, Annelien
collection PubMed
description BACKGROUND: Cluster headache is classified as a primary headache by definition not caused by an underlying pathology. However, symptomatic cases of otherwise typical cluster headache have been reported. CASE PRESENTATION: A 47-year-old male suffered from primary chronic cluster headache (CCH, ICHD-3 beta criteria fulfilled) since the age of 35 years. A magnetic resonance imaging (MRI) study of the brain in 2006 came back normal. He tried several prophylactic treatments but was never longer than 1 month without attacks. He was under chronic treatment with verapamil with only a limited effect on the attack frequency. Subcutaneous sumatriptan 6 mg injections were very effective in aborting attacks. By February 2014 the patient developed a continuous interictal pain ipsilateral to the right-sided cluster headache attacks. An indomethacin test (up to 225 mg/day orally) was negative. Because of the change in headache pattern we performed a new brain MRI, which showed a cystic structure in the pituitary gland. The differential diagnosis was between a Rathke cleft cyst and a cystic adenoma. Pituitary function tests showed an elevated serum prolactin level. A dopamine agonist (cabergoline) was started and the headache subsided completely. Potential pathophysiological mechanisms of pituitary tumor-associated headache are discussed. CONCLUSION: Neuroimaging should be considered in all patients with CCH, especially those with an atypical presentation or evolution. Response to acute treatment does not exclude a secondary form of cluster headache. There may be shared pathophysiological mechanisms of primary and secondary cluster headache.
format Online
Article
Text
id pubmed-4788665
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-47886652016-04-09 Chronic cluster headache and the pituitary gland De Pue, Annelien Lutin, Bart Paemeleire, Koen J Headache Pain Case Report BACKGROUND: Cluster headache is classified as a primary headache by definition not caused by an underlying pathology. However, symptomatic cases of otherwise typical cluster headache have been reported. CASE PRESENTATION: A 47-year-old male suffered from primary chronic cluster headache (CCH, ICHD-3 beta criteria fulfilled) since the age of 35 years. A magnetic resonance imaging (MRI) study of the brain in 2006 came back normal. He tried several prophylactic treatments but was never longer than 1 month without attacks. He was under chronic treatment with verapamil with only a limited effect on the attack frequency. Subcutaneous sumatriptan 6 mg injections were very effective in aborting attacks. By February 2014 the patient developed a continuous interictal pain ipsilateral to the right-sided cluster headache attacks. An indomethacin test (up to 225 mg/day orally) was negative. Because of the change in headache pattern we performed a new brain MRI, which showed a cystic structure in the pituitary gland. The differential diagnosis was between a Rathke cleft cyst and a cystic adenoma. Pituitary function tests showed an elevated serum prolactin level. A dopamine agonist (cabergoline) was started and the headache subsided completely. Potential pathophysiological mechanisms of pituitary tumor-associated headache are discussed. CONCLUSION: Neuroimaging should be considered in all patients with CCH, especially those with an atypical presentation or evolution. Response to acute treatment does not exclude a secondary form of cluster headache. There may be shared pathophysiological mechanisms of primary and secondary cluster headache. Springer Milan 2016-03-11 /pmc/articles/PMC4788665/ /pubmed/26969187 http://dx.doi.org/10.1186/s10194-016-0614-0 Text en © De Pue et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
De Pue, Annelien
Lutin, Bart
Paemeleire, Koen
Chronic cluster headache and the pituitary gland
title Chronic cluster headache and the pituitary gland
title_full Chronic cluster headache and the pituitary gland
title_fullStr Chronic cluster headache and the pituitary gland
title_full_unstemmed Chronic cluster headache and the pituitary gland
title_short Chronic cluster headache and the pituitary gland
title_sort chronic cluster headache and the pituitary gland
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788665/
https://www.ncbi.nlm.nih.gov/pubmed/26969187
http://dx.doi.org/10.1186/s10194-016-0614-0
work_keys_str_mv AT depueannelien chronicclusterheadacheandthepituitarygland
AT lutinbart chronicclusterheadacheandthepituitarygland
AT paemeleirekoen chronicclusterheadacheandthepituitarygland